Correlation Between Inhibikase Therapeutics and Avantor
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Avantor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Avantor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Avantor, you can compare the effects of market volatilities on Inhibikase Therapeutics and Avantor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Avantor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Avantor.
Diversification Opportunities for Inhibikase Therapeutics and Avantor
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inhibikase and Avantor is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Avantor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avantor and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Avantor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avantor has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Avantor go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Avantor
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 3.4 times more return on investment than Avantor. However, Inhibikase Therapeutics is 3.4 times more volatile than Avantor. It trades about 0.04 of its potential returns per unit of risk. Avantor is currently generating about 0.02 per unit of risk. If you would invest 288.00 in Inhibikase Therapeutics on September 12, 2024 and sell it today you would earn a total of 32.00 from holding Inhibikase Therapeutics or generate 11.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Avantor
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Avantor |
Inhibikase Therapeutics and Avantor Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Avantor
The main advantage of trading using opposite Inhibikase Therapeutics and Avantor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Avantor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avantor will offset losses from the drop in Avantor's long position.| Inhibikase Therapeutics vs. Equillium | Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Valneva SE ADR | Inhibikase Therapeutics vs. Vivani Medical |
| Avantor vs. Ashland Global Holdings | Avantor vs. H B Fuller | Avantor vs. Element Solutions | Avantor vs. Balchem |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |